Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is Whom We are Dealing With:

Re: This is Whom We are Dealing With: Yo Hombre

posted on Aug 03, 2009 12:21PM

I dont think Leckrone has used PTSC money....... PTSC recieves 50% of the revenue of the license and its not subjected to deductions for the cost of signing this revenue..( that falls on TPL alone). Its also my understanding that the legal fees/costs are handled separately by PTSC and TPL....

i think its been pretty clear and evident that problem is arising from the TPL share of the MMP license...

Eg. XXXX company signs for $1 million dollars / 50% of that goes to PTSC and the other 50% goes to TPL. The $500,000 reserved for TPL is then split internally for Moore and TPL projects..... Moore & Leckrone were working on new projects together and more than likely Leckrone "used" Moores comissions/profits to fund their projects together..... Moore seems to think that this royalties should not have been used... or at least the costs deducted are not acceptable to him. Projects got cut and now they trying to find out who owes what and to whom..

Share
New Message
Please login to post a reply